GlassScriptPhysician profile
Alexander Gp Capelli
NPI 1134225311
$2,217.05
in general payments reported to CMS, 2019-2025
20 companies · $435 in 2025
The $435 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $263 · 2021: $253 · 2022: $148 · 2023: $313 · 2024: $427 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,175.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $447.52 | 2019-2023 | |
| Astellas Pharma US INC | $414.58 | 2022-2025 | Veozah |
| Mayne Pharma Commercial LLC | $197.58 | 2021-2025 | |
| Abbvie INC. | $189.53 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $184.95 | 2024-2025 | Myfembree, Gemtesa |
| Intuitive Surgical, INC. | $129.97 | 2019-2020 | |
| Novo Nordisk INC | $107.64 | 2024-2025 | Wegovy |
| Ethicon US, LLC | $105.59 | 2019-2020 | |
| Organon LLC | $74.58 | 2022-2024 | |
| Therapeuticsmd, INC. | $72.27 | 2019-2020 | |
| Exact Sciences Corporation | $51.41 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $45.38 | 2020 | |
| Avion Pharmaceuticals | $44.89 | 2021 | |
| Exeltis, USA INC. | $35.34 | 2024-2025 | Slynd |
| Hologic Sales and Service, LLC | $29.04 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $22.00 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $17.88 | 2021 | |
| Lupin INC. | $16.36 | 2020 | |
| Allergan, INC. | $16.19 | 2019 | |
| Daiichi Sankyo INC. | $14.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Capelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.